Bipartisan bill for biogenerics unveiled in Congress

03/11/2009 | Reuters · Google

Reps. Henry Waxman, D-Calif., and Nathan Deal, R-Ga., introduced a proposal that would allow the FDA to approve generic versions of biotech medicines. The bill, which would give brand-name biotech drugs three to five years of market exclusivity, would "lead to healthy competition and long-term savings for patients and payers" and "preserve innovation in the biotech marketplace," Waxman said.

View Full Article in:

Reuters · Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA